Growing miniature tumor models for aggressive brain cancer
Part of Cancer clinical trials.
This study is testing whether it's possible to grow a miniature model of your brain tumor (called an organoid) from a small sample taken during surgery. The goal is to better understand your tumor's specific makeup, which might help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a type of brain tumor called a high-grade glioma, suspected from an MRI scan.
- You are scheduled to have surgery to remove the tumor.
- You are healthy enough to have radiation therapy and chemotherapy (temozolomide) after surgery, with or without Tumor Treating Fields.
- You have not had another cancer (treated and cured within the last 2 years).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lab-grown model of your tumor (called an organoid) to test whether different drugs might work against it. The goal is to find the best treatment for your specific glioblastoma.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This early-phase trial tests a tiny implanted device placed during brain tumor surgery. It delivers very small doses of medicine directly to the tumor area for a short time, aiming to see if this approach is safe and workable in patients with certain gliomas.
This study looks at how different treatments and patient factors affect outcomes in people with glioblastoma, an aggressive type of brain tumor. By joining, you help researchers learn which approaches work best, which could improve care for future patients.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial tests a special MRI technique to guide surgeons in removing more of the brain tumor during surgery. The goal is to help people with glioblastoma live longer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.